Antibody News

Learn how anti-HIV vaccines are advancing towards the clinic and how investigators are devising vaccine strategies to promote anti-HIV neutralizing and non-neutralizing antibodies.

Learn how a new strategy takes advantage of a highly potent form of IL-6 to promote spinal neuron regeneration and restore function after spinal cord injury.

Learn about the Human Cell Atlas Organoid initiative for the characterization of human organoids at the single cell level which aims to develop standards for the generation and application of organoids for research, precision, and regenerative medicine.

Learn about new phosphorylated tau biomarkers which may facilitate Alzheimer's disease early diagnosis.

Discovering Antibodies with Broader Epitope Specificities

Severe Respiratory Infections: New Mechanism for Pathology

Potential Monoclonal Antibody Drugs for Seasonal Influenza

Phase 1 and 2 Human Trials Reveal Safety and immunogenicity of the ChAdOx1 nCoV-19 Vaccine

The spike (S) glycoprotein of the coronavirus SARS-CoV-2 is responsible for viral entry into human cells by directly binding the angiotensin-converting enzyme 2 (ACE2) expressed on the cell surface by many cell types.

In September this year, Kenya made history by becoming the first country to launch the world’s first ever malaria vaccine pilot program.